This learning series includes:
- 1 hr 9 mins of on-demand video
- Access on desktop, tablet and mobile
- Certificate of completion
Join Professor Samuele Cortese as he unpacks the latest evidence on ADHD treatment. This series explores both pharmacological and non-pharmacological approaches, offering practical insights for clinicians. Gain a deeper understanding of how to interpret and apply research findings in real-world practice.
In this talk, Professor Samuele Cortese discusses current pharmacological treatments for ADHD, referencing the latest NICE guidelines and a significant European ADHD Guidelines Group network meta-analysis. He explores the efficacy and tolerability of ADHD medications, specifically comparing stimulants like methylphenidate and amphetamines. The analysis addresses both short-term effects and long-term implications, highlighting the importance of balancing efficacy with tolerability in clinical practice.
A. To understand the sequence of pharmacological treatments for ADHD as recommended by NICE guidelines, starting with methylphenidate. B. To evaluate the efficacy and tolerability of different ADHD medications using network meta-analysis findings. C. To assess the long-term effects of ADHD medications on quality of life and other serious outcomes through meta-analysis and observational studies.
Join Professor Samuele Cortese, one of the world’s most influential researchers of the past decade, for a comprehensive 4-hour clinical expert session on ADHD, designed specifically for mental health professionals working with children, adolescents, and families.
Explore the EBI-ADHD platform bringing together research on treatment effectiveness and safety
Full Professor of Child and Adolescent Psychiatry at the University of Southampton
Download conflict of interest form